Loading
  • Babraham Hall CambridgeAberystwyth Innovation and Enterprise Campus Aberystwyth
  • Call us on +44 (0) 1223 804075

New Chairman Brings “Wealth of Experience” to Pioneering Biotech Firm Simon Sturge, Executive Vice President of Business, Operations and Strategy at Merck Healthcare, is today confirmed as the new Chairman of Nemesis Bioscience, the British biotechnology business tackling antibiotic resistance with breakthrough technologies. This is a very significant appointment for Nemesis given Mr Sturge’s extensive career in senior roles across the pharmaceutical and biotech sectors. He founded RiboTargets; served as